118 related articles for article (PubMed ID: 3936648)
1. The response of obese subjects to continuous infusion of human pancreatic growth hormone-releasing factor 1-44.
Davies RR; Turner SJ; Cook D; Alberti KG; Johnston DG
Clin Endocrinol (Oxf); 1985 Nov; 23(5):521-5. PubMed ID: 3936648
[TBL] [Abstract][Full Text] [Related]
2. Plasma growth hormone and somatomedin-C responses to continuous growth hormone-releasing factor infusion in normal adult men.
Takano K; Honda N; Shizume K; Hizuka N; Ling NC
Endocrinol Jpn; 1985 Apr; 32(2):287-93. PubMed ID: 3930225
[TBL] [Abstract][Full Text] [Related]
3. [The effect of synthetic human pancreatic growth hormone-releasing factor (hpGRF-44) on serum growth hormone response in normal and obese subjects].
Shimizu T; Inoue K
Nihon Naibunpi Gakkai Zasshi; 1986 Feb; 62(2):82-96. PubMed ID: 3084310
[TBL] [Abstract][Full Text] [Related]
4. The response of normal subjects and patients with idiopathic growth hormone deficiency to continuous infusion of human pancreatic growth hormone releasing factor 1-44.
Davies RR; Turner SJ; Parkin JM; Johnston DG
Clin Endocrinol (Oxf); 1984 Nov; 21(5):569-74. PubMed ID: 6437706
[TBL] [Abstract][Full Text] [Related]
5. Impaired growth hormone response to growth hormone releasing factor and insulin-hypoglycaemia in obesity.
Kopelman PG; Noonan K; Goulton R; Forrest AJ
Clin Endocrinol (Oxf); 1985 Jul; 23(1):87-94. PubMed ID: 2863016
[TBL] [Abstract][Full Text] [Related]
6. Reduced growth hormone response to growth hormone-releasing hormone in children with simple obesity: evidence for somatomedin-C mediated inhibition.
Loche S; Cappa M; Borrelli P; Faedda A; Crinò A; Cella SG; Corda R; Müller EE; Pintor C
Clin Endocrinol (Oxf); 1987 Aug; 27(2):145-53. PubMed ID: 3117449
[TBL] [Abstract][Full Text] [Related]
7. Growth hormone response to low dose intravenous injections of growth hormone releasing factor in obese and normal weight women.
Kopelman PG; Noonan K
Clin Endocrinol (Oxf); 1986 Feb; 24(2):157-64. PubMed ID: 2871950
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone and somatomedin-C response to synthetic human pancreatic tumor GH-releasing factor in hypopituitary and constitutionally short children.
Minuto F; Barreca A; Del Monte P; Mauri R; Resentini M; Fortini P; Morabito M; Giordano G
J Endocrinol Invest; 1986 Dec; 9(6):447-52. PubMed ID: 3106458
[TBL] [Abstract][Full Text] [Related]
9. Enhanced growth hormone (GH) responsiveness to GH-releasing hormone after dietary manipulation in obese and nonobese subjects.
Kelijman M; Frohman LA
J Clin Endocrinol Metab; 1988 Mar; 66(3):489-94. PubMed ID: 3127415
[TBL] [Abstract][Full Text] [Related]
10. Effects of human pancreatic tumour growth hormone releasing factor on growth hormone and somatomedin C levels in patients with idiopathic growth hormone deficiency.
Borges JL; Blizzard RM; Gelato MC; Furlanetto R; Rogol AD; Evans WS; Vance ML; Kaiser DL; MacLeod RM; Merriam GR; Loriaux DL; Spiess J; Rivier J; Vale W; Thorner MO
Lancet; 1983 Jul; 2(8342):119-24. PubMed ID: 6134978
[TBL] [Abstract][Full Text] [Related]
11. Short-term fasting in obesity fails to restore the blunted GH responsiveness to GH-releasing hormone alone or combined with arginine.
Procopio M; Maccario M; Grottoli S; Oleandri SE; Boffano GM; Camanni F; Ghigo E
Clin Endocrinol (Oxf); 1995 Dec; 43(6):665-9. PubMed ID: 8736266
[TBL] [Abstract][Full Text] [Related]
12. Circulating somatomedin-C levels and the effect of growth hormone-releasing factor on plasma levels of growth hormone and somatostatin-like immunoreactivity in obese children.
Rosskamp R; Becker M; Soetadji S
Eur J Pediatr; 1987 Jan; 146(1):48-50. PubMed ID: 2884108
[TBL] [Abstract][Full Text] [Related]
13. Effects of human pancreatic growth hormone-releasing factor-40 on serum growth hormone, prolactin, luteinizing hormone, follicle-stimulating hormone, and somatomedin-C concentrations in normal women throughout the menstrual cycle.
Evans WS; Borges JL; Vance ML; Kaiser DL; Rogol AD; Furlanetto R; Rivier J; Vale W; Thorner MO
J Clin Endocrinol Metab; 1984 Nov; 59(5):1006-10. PubMed ID: 6434583
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of growth hormone (GH) and somatomedin C in idiopathic GH-deficient subjects by intermittent pulsatile administration of synthetic human pancreatic tumor GH-releasing factor.
Borges JL; Blizzard RM; Evans WS; Furlanetto R; Rogol AD; Kaiser DL; Rivier J; Vale W; Thorner MO
J Clin Endocrinol Metab; 1984 Jul; 59(1):1-6. PubMed ID: 6427267
[TBL] [Abstract][Full Text] [Related]
15. An abnormality of the growth hormone/insulin-like growth factor-I axis in women with polycystic ovary syndrome due to coexistent obesity.
Slowinska-Srzednicka J; Zgliczynski W; Makowska A; Jeske W; Brzezinska A; Soszynski P; Zgliczynski S
J Clin Endocrinol Metab; 1992 Jun; 74(6):1432-5. PubMed ID: 1534330
[TBL] [Abstract][Full Text] [Related]
16. Changes in growth hormone (GH) secretion induced by human pancreatic GH releasing hormone-44 in acromegaly: a comparison with thyrotropin-releasing hormone and bromocriptine.
Chiodini PG; Liuzzi A; Dallabonzana D; Oppizzi G; Verde GG
J Clin Endocrinol Metab; 1985 Jan; 60(1):48-52. PubMed ID: 3917270
[TBL] [Abstract][Full Text] [Related]
17. Elevated insulin levels contribute to the reduced growth hormone (GH) response to GH-releasing hormone in obese subjects.
Lanzi R; Luzi L; Caumo A; Andreotti AC; Manzoni MF; Malighetti ME; Sereni LP; Pontiroli AE
Metabolism; 1999 Sep; 48(9):1152-6. PubMed ID: 10484056
[TBL] [Abstract][Full Text] [Related]
18. Cholinergic receptor activation by pyridostigmine restores growth hormone (GH) responsiveness to GH-releasing hormone administration in obese subjects: evidence for hypothalamic somatostatinergic participation in the blunted GH release of obesity.
Cordido F; Casanueva FF; Dieguez C
J Clin Endocrinol Metab; 1989 Feb; 68(2):290-3. PubMed ID: 2493023
[TBL] [Abstract][Full Text] [Related]
19. Acipimox potentiates growth hormone (GH) response to GH-releasing hormone with or without pyridostigmine by lowering serum free fatty acid in normal and obese subjects.
Lee EJ; Nam SY; Kim KR; Lee HC; Cho JH; Nam MS; Song YD; Lim SK; Huh KB
J Clin Endocrinol Metab; 1995 Aug; 80(8):2495-8. PubMed ID: 7629249
[TBL] [Abstract][Full Text] [Related]
20. Corticosteroid-induced growth hormone secretion in normal and obese subjects.
Muruais C; Cordido F; Morales MJ; Casanueva FF; Diéguez C
Clin Endocrinol (Oxf); 1991 Dec; 35(6):485-90. PubMed ID: 1769129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
